Search for: "AMGEN INC."
Results 521 - 540
of 704
Sorted by Relevance
|
Sort by Date
23 Sep 2014, 1:25 pm
by Dennis Crouch In Abbvie Inc. v. [read post]
4 Mar 2014, 7:31 am
Most recently, in last year’s decision in Amgen v. [read post]
6 Aug 2013, 8:36 am
See Southwall Tech., Inc. v. [read post]
7 Jan 2014, 11:38 pm
They propose a “meaningful modification” of the Court’s holding in Basic, Inc. v. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
16 May 2012, 12:22 pm
Amgen, Inc., 2012 WL 517446, at *3 (W.D. [read post]
20 Aug 2010, 5:46 pm
” Amgen Inc. v. [read post]
24 Nov 2010, 8:22 am
Patent No. 7,511,043 owned by Amgen and entitled FXR MODULATIONS. [read post]
24 Nov 2010, 8:22 am
Patent No. 7,511,043 owned by Amgen and entitled FXR MODULATIONS. [read post]
3 Jun 2016, 6:40 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
6 May 2016, 12:30 pm
See Centocor, Inc. v. [read post]
24 Feb 2022, 6:12 pm
” Full Scope Enablement: Amgen v. [read post]
18 May 2016, 8:19 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
18 Apr 2016, 9:58 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
3 May 2016, 1:42 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
1 Apr 2016, 8:22 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
14 Jan 2016, 11:43 am
Well, Amgen Inc. v. [read post]
1 Feb 2016, 10:43 am
’”Greenliant, 692 F.3d at 1268 (quoting Amgen, 580 F.3d at1340). [read post]
17 Mar 2016, 2:45 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
5 Mar 2013, 6:16 am
But, the initial merits inquiry required by the vindication of rights doctrine would seem to be at odds philosophically with Justice Ginsburg’s recent opinion in Amgen v. [read post]
